| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |